Unlock instant, AI-driven research and patent intelligence for your innovation.

Inhibitor of stem cell proliferation and uses thereof

A technology of sequence, cysteine ​​residue, applied in application, genetic engineering, plant genetic improvement, etc., can solve the problems of increased infection rate, low stem cell frequency and high susceptibility

Inactive Publication Date: 2009-12-23
WELLSTAT THERAPEUTICS
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0025] There are several limitations in introducing genes into human hematopoietic cells using retroviral vectors or physical techniques of gene transfer: (1) The frequency of stem cells in hematopoietic tissues is low, and efficient gene transfer technology must be developed; (2) Stem cells with shorter cycles The higher the susceptibility to the vector, but the increased infection rate by stimulating stem cell proliferation with growth factors has the opposite effect on long-term gene expression
Because, cells containing the transgene are forced to undergo irreversible differentiation and lose their ability to self-renew

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibitor of stem cell proliferation and uses thereof
  • Inhibitor of stem cell proliferation and uses thereof
  • Inhibitor of stem cell proliferation and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0155] Example 1: In vivo stem cell proliferation inhibition assay

[0156] To measure the proliferation of stem cells, by 3 The H-TdR "suicide method" measures the number of CFU-S in the S phase of the cell cycle (Becker et al., Blood 26:296-308, 1965).

[0157] Immature hematopoietic progenitors - colony-forming units of the spleen (CFU-S) can be detected in vivo by macroscopic colonies formed in the spleen of lethally irradiated mice 8-12 days after intravenous injection of hematopoietic cells (Till & McCulloch 1961).

[0158] For standard CFU-S proliferation assays, typically 3 H-TdR "Suicide Method" (Becker et al., 1965). The method is based on radiolabeled thymine ( 3 H-TdR) is incorporated into cells as a synthetic DNA precursor. CFU-S, which was in the S phase of the cell cycle at the time of detection, was killed by high radioactivity and thus failed to form colonies in the spleen. Then, by injecting with 3 H-TdR co-cultured cell samples and no 3 The differe...

Embodiment 2

[0177] Example 2 In vitro stem cell proliferation inhibition analysis

[0178] The direct effect of INPROL was shown using the following detection system (Lord et al., The Inhibitors of Hematopoiesis, pp. 227-239, 1987). Multilineage factor (IL-3) dependent cell line FDCP mix A 4 (A 4 ), maintained in IMDM medium containing 20% ​​horse serum and 10% WEHI-3 conditioned medium as a source of colony-stimulating IL-3.

[0179] use 3 Proliferation detected by H-TdR incorporation assay: A 4 cells (5×10 4 in 100 μl medium containing 20% ​​horse serum and 50% WEHI-3 conditioned culture supernatant) at 37°C, 5% CO 2 cultured for 16 hours.

[0180] Begin adding INPROL or crude BME (Bone Marrow Extract) (Component IV), then add to each group 3 H-TdR (3.7KBq in 50μl at 740GBq / mmol) was incubated for an additional 3 hours. Proliferation rates were determined by harvesting cells and calculating percent inhibition using the following formula.

[0181]

[0182] FDCPmix-A grown i...

Embodiment 3

[0183] Example 3 In vivo injection of INPROL results in inhibition of CFU-S proliferation: dose and effect duration

[0184] The effects of INPROL injection in vivo showed that INPROL could effectively block the recruitment of CFU-S into the cell cycle. Thus, these cells are protected from cytotoxic effects upon further treatment. It shows its potential clinical application value.

[0185] This protocol has two objectives: to examine the effect of INPROL on CFU-S when injected in vivo and to determine the effective duration of INPROL activity involving cell cycle stem cells.

[0186] To stimulate CFU-S proliferation, according to the effects mentioned in Example 1, testosterone propionate (TSP) was injected.

[0187] BDF in 0 days 1 Mice were injected with TSP (10mg / 100g), and 24 hours later, mice in each experimental group (4 mice / group) were intraperitoneally injected with pINPROL 0μg, 5μg, 10μg and 15μg / mouse.

[0188] Twenty-four hours after pINPROL injection, mice...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

Disclosed and claimed are the isolation and application of stem cell inhibitory factors that regulate abnormal stem cell cycle and accelerate peripheral blood recovery after chemotherapy. Also disclosed and claimed are inhibitors of stem cell proliferation.

Description

[0001] This application is a divisional application of an invention patent application with an application date of September 29, 1995, an application number of 95196555.7, and an invention title of "Stem Cell Proliferation Inhibitor and Its Application". Field of Invention [0002] The present invention relates to the use of a stem cell proliferation inhibitory factor that modulates the stem cell cycle in the treatment of humans or animals suffering from autoimmune disease, aging, cancer, myelodysplasia, pre-leukemia, leukemia, psoriasis or other diseases involving hyperproliferative conditions . The present invention also relates to methods of treatment of humans or animals that have been previously or have been exposed to chemotherapeutic drugs, other drugs that damage the stem cell cycle, or radiation. Finally, the present invention relates to improvements in the maintenance or expansion of stem cells for autologous and allogeneic transplantation methods or for gene transfe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/08A61K38/00C07K1/00C12N5/00C12N15/00A61KC07KC12N
Inventor V·科兹洛夫I·楚尔洛娃S·D·沃尔帕
Owner WELLSTAT THERAPEUTICS